AstraZeneca said on Monday its experimental precision drug developed with Japan's Daiichi Sankyo did not significantly ...

This summary covers various health news briefs including AstraZeneca's breast cancer drug trial results, a bird flu case in ...

It said the drug did not 'achieve statistical significance' in terms of the survival rates of those suffering from breast ...

This article from Molecular Devices explores how cell painting can be used in a 3D breast cancer spheroid model for ...

Nearly 200 chemicals connected to breast cancer are used in the making of food packaging and plastic tableware, and dozens of ...

Experts from the University of of Dundee's Centre for Targeted Protein Degradation (CeTPD), working with Boehringer Ingelheim scientists, have developed a breakthrough small-molecule drug, a "protein ...

Researchers leading the SWOG S1712 clinical trial have found that adding ruxolitinib to standard tyrosine kinase inhibitor ...

Experts have developed a breakthrough small-molecule drug, a 'protein degrader'. This molecule, called ACBI3, could potentially lead to new therapies independent of KRAS mutation type, improving ...

The uptick in AstraZeneca share price came after the company announced that it has received permission to import for sale and ...

This is to inform you that AstraZeneca Pharma India Limited has received permission from the Central Drugs Standard Control ...

Multiple myeloma (MM) is a type of blood cancer that typically has no cure. Treatments like medications and stem cell ...

AstraZeneca released results from the TROPION-Breast01 Phase 3 trial of datopotamab deruxtecan, showing no statistically ...